| 标题 |
[高分] Dalpiciclib versus placebo in combination with letrozole or anastrozole asfirst-line treatment for women with HR+/HER2- advanced breast cancer:prespecified final analysis of progression-free survival of the phase 3 DAWNA-2trial
Dalpiciclib与安慰剂联合来曲唑或阿那曲唑作为HR+/HER2-晚期乳腺癌女性一线治疗的比较：3期DAWNA-2试验无进展生存期的预先指定最终分析
|
| 备注 |
我要徐兵河教授在2024年SABCS上的壁报或者汇报PPT，不要摘要
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
2024 SABCS PS2-01: Dalpiciclib versus placebo in combination with letrozole or anastrozole asfirst-line treatment for women with HR+/HER2- advanced breast cancer:prespecified final analysis of progression-free survival of the phase 3 DAWNA-2trial. Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Being, China |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
eric888
浮游
唐泽雪穗
LaTeXer
tuanheqi
小青椒
xzy998
子车茗
从容芮
iNk
GingerF
ceeray23
Bio
Tourist
Criminology34
风清扬
pluto
菠菜
star
Gauss
8R60d8
yangjiafengzi
lalala
Antheali
pcr163
Li
老阎
哈哈哈哈哈
皖公网安备34019202002308
